China's Kunming Pharma To Build Manufacturing Plant in Uzbekistan
This article was originally published in PharmAsia News
Executive Summary
China-based Kunming Pharmaceutical plans to build a drug manufacturing plant in Uzbekistan capable of producing 2 million doses of its drug to treat bronchopulmonary problems.